Please login to the form below

Not currently logged in
Email:
Password:

rheumatoid arthritis

This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

Olumiant is already approved for use as a treatment for rheumatoid arthritis, and is a one of a group of anti-inflammatory drugs that have been studied as potential COVID-19

Latest news

More from news
Approximately 56 fully matching, plus 433 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 40 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics